Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-avxl
/
Anavex Life Sciences Corp
AVXL
Add to Watchlist
2.760
USD
+0.180
+6.98%
Close 07/02, 13:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
239.21M
Market Cap
Loss
P/E TTM
Anavex Life Sciences Corp
2.760
+0.180
+6.98%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Wed, May 13
Updated: Wed, May 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.19%
State Street Investment Management (US)
4.73%
Vanguard Capital Management, LLC
4.17%
Two Sigma Investments, LP
3.11%
Geode Capital Management, L.L.C.
2.18%
Other
78.61%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.19%
State Street Investment Management (US)
4.73%
Vanguard Capital Management, LLC
4.17%
Two Sigma Investments, LP
3.11%
Geode Capital Management, L.L.C.
2.18%
Other
78.61%
Shareholder Types
Shareholders
Proportion
Investment Advisor
21.27%
Investment Advisor/Hedge Fund
11.01%
Hedge Fund
4.72%
Individual Investor
3.12%
Research Firm
2.55%
Bank and Trust
0.75%
Pension Fund
0.23%
Venture Capital
0.11%
Insurance Company
0.02%
Other
56.22%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
369
37.30M
40.25%
+1.05M
2025Q4
361
33.18M
40.32%
+16.73K
2025Q3
374
33.16M
42.26%
+53.90K
2025Q2
368
33.05M
40.68%
+750.54K
2025Q1
357
32.28M
37.21%
+528.38K
2024Q4
346
29.86M
35.43%
+2.39M
2024Q3
332
27.21M
35.57%
+180.66K
2024Q2
332
27.06M
40.00%
-5.09M
2024Q1
328
32.30M
34.03%
+4.36M
2023Q4
332
26.28M
33.24%
+710.68K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.67M
7.19%
+334.52K
+5.28%
Dec 31, 2025
State Street Investment Management (US)
4.38M
4.73%
+1.10M
+33.35%
Dec 31, 2025
Two Sigma Investments, LP
2.88M
3.11%
+1.09M
+60.67%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.02M
2.18%
-4.42K
-0.22%
Dec 31, 2025
Missling (Christopher U)
1.51M
1.63%
--
--
Nov 24, 2025
Skarpelos (Athanasios)
1.31M
1.41%
--
--
Nov 24, 2025
Summit Financial, LLC
903.39K
0.97%
+459.12K
+103.34%
Dec 31, 2025
Goldman Sachs & Company, Inc.
758.56K
0.82%
+621.63K
+453.96%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
0.53%
ALPS Medical Breakthroughs ETF
0.27%
State Street SPDR S&P Biotech ETF
0.21%
iShares Micro-Cap ETF
0.13%
Direxion Daily S&P Biotech Bull 3X Shares
0.13%
Vanguard US Momentum Factor ETF
0.08%
Invesco Nasdaq Biotechnology ETF
0.07%
iShares Biotechnology ETF
0.06%
iShares ESG Aware MSCI USA Small-Cap ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
View more
iShares Neuroscience and Healthcare ETF
Proportion
0.53%
ALPS Medical Breakthroughs ETF
Proportion
0.27%
State Street SPDR S&P Biotech ETF
Proportion
0.21%
iShares Micro-Cap ETF
Proportion
0.13%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.13%
Vanguard US Momentum Factor ETF
Proportion
0.08%
Invesco Nasdaq Biotechnology ETF
Proportion
0.07%
iShares Biotechnology ETF
Proportion
0.06%
iShares ESG Aware MSCI USA Small-Cap ETF
Proportion
0.04%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.04%